News|Videos|November 17, 2026

Executive Conversations: Why Channel Design Should Start With the Patient

In Episode 2, Part 1, Cheryl Allen, Nick Calla and Rena Goins discuss whether today's channel models are ready for an increasingly complex pipeline.

The second episode of Executive Conversations: The Future of Pharmaceutical Commercialization, presented by Pharmaceutical Commerce, opens by asking whether the channel models the industry has relied on are designed for an increasingly complex pipeline of cell and gene therapies, radiopharmaceuticals, precision medicines and highly specialized products. Cheryl Allen, partner at Curatio Advisors, moderates the discussion with Nick Calla, senior vice president of industry relations at Orsini Specialty Pharmacy, and Rena Goins, executive director, global trade at Regeneron Pharmaceuticals.

Related to this article